Report: Schweitzer to step down as AstraZeneca's chairman

AstraZeneca ($AZN) is on the hunt for a new chairman. Louis Schweitzer, who's filled that role since 2005, is stepping down, Sky News reports.

John Varley, currently a non-executive director at AstraZeneca, was approached about the vacancy. However, Varley, a former chief executive of Barclays, isn't likely to end up in the slot, Sky News' sources said. Executive search firm MWM Consulting is said to be handling the search. AstraZeneca wouldn't comment.

The 68-year-old Schweitzer also chairs the board at Volvo. He previously ran the French automaker Renault.

- read the Sky News piece

Suggested Articles

Last year at ESMO, AZ and Merck showed Lynparza topped its rivals at fending off prostate cancer. Now, Lynparza has helped patients live longer, too.

Merck and Eisai are trying to take their Keytruda-Lenvima combo into additional cancers, and new data provide a glimpse of where it might go next.

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.